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Renal medullary carcinoma (RMC) is a rare and aggressive ma-
lignant epithelial neoplasm of the kidney. It almost exclusively
affects children and young adults with a sickle cell trait or sickle
cell disease. The majority of RMC patients present with widely
disseminated disease at the time of diagnosis. Herein, we report
two cases of young African-American patients with history of
sickle cell trait, hematuria and renal mass, who present with ma-
lignant right pleural effusions. The cytology of pleural effusion
reveals predominantly clusters and individual tumor cells. The tu-
mor cells show high nuclear to cytoplasmic (NC) ratios and large
nuclei with nuclear pleomorphism, nuclear grooves, and promi-
nent single or multiple nucleoli. The cytoplasm is dense with a
vacuolated and two-tone appearance. Surgical specimens of renal
mass and lymph node show features of RMC.
Metastatic RMC to the serous cavity is rare and may present
a diagnostic dilemma since it may mimic a poorly differentiated
adenocarcinoma or other high-grade malignant neoplasms.
RMC should be considered in the differential diagnosis in young
patients with a renal mass, particularly in those with history of
sickle cell trait or sickle cell disease. Diagn. Cytopathol.
2009;37:843–848. ' 2009 Wiley-Liss, Inc.
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Renal medullary carcinoma (RMC) is a highly aggressive
malignant epithelial neoplasm of the kidney. Since the
first description by Davis CJ in 1995, more than one hun-
dred cases have been reported in the literature.1–10 It
almost exclusively affects children and young adults with
a history of sickle cell trait or sickle cell disease. The av-
erage age of patients is 21 years, and the male to female
ratio is 2.2:1.0. Clinically, the most common symptoms
are hematuria, abdominal pain, weight loss and renal
mass. The majority of RMC patients present with widely
disseminated disease at the time of diagnosis.
The origin of RMC is still unknown, but it has been sug-
gested that RMC may arise from the calyceal epithelium of
the renal pelvis or near the renal papillae.1 Histologically,
the most notable features of RMC are reticular and compact
adenoid cystic growth patterns with focal solid area.1,2,6,7
The cells are high-grade malignant cells with prominent
nucleoli. In solid area, the cells may have rhabdoid or plas-
macytoid features. Neutrophil infiltration and microabscess
formation can be found in the desmoplastic stroma.1,2,6,7
RMC may present as a diagnostic dilemma, particularly
when it metastasizes outside of the kidney.
Herein, we report two cases of metastatic RMC pre-
senting with right sided malignant pleural effusions. The
cytological features of RMC in the exfoliative specimens
are readily identified as malignant effusion; however, they
have some features that overlap with other high-grade ma-
lignant neoplasms, such as adenocarcinoma, renal cell
carcinoma, urothelial cell carcinoma, collecting duct car-
cinoma and few others. The purpose of this work is to
summarize the cytological findings of metastatic RMC in
the pleural effusion and to discuss relevant features of the
differential diagnoses.
Materials and Methods
Two cytospins were prepared from each pleural effusion
specimen. These were fixed in 95% ethanol and stained
by Papanicolaou method. Cell blocks were also prepared,
fixed in formalin and processed in the histology labora-
tory according to standard protocols. The sections of the
cell block were stained with hematoxylin and eosin
(H&E) method.
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Immunohistochemical studies were performed on the
cell block material. The sections were cut at four micron
thickness and deparaffinized before incubation with pri-
mary antibodies. Heat antigen retrieval at 708C for
40 minutes was also used to enhance the signal detection.
The immunohistochemistry was performed by using a
Dako autostrainer. The dilutions of primary antibodies
were used according to manufacturer’s suggestions and
standard protocols. The information of primary antibodies
was summarized in Table I.
Results
Clinical Findings
Case 1. A 26-year-old African-American male with a
history of sickle cell trait presented with cough, fevers,
shortness of breath, and was clinically suspected to have
an upper respiratory tract infection. Chest X-ray showed
infiltrates of the right middle and lower lobes. The patient
was treated symptomatically, however, the symptoms per-
sisted; and the patient subsequently developed a right
pleural effusion, weight loss and hematuria. A computer-
ized tomography (CT) scan and positron emission tomog-
raphy-computed tomography (PET-CT) demonstrated a
large (7.8 3 6.2 3 6.2 cm) right renal mass and multiple
lesions in both lobes of the lungs, the liver and the adre-
nal glands. The patient also had an extensive retroperito-
neal lymphadenopathy. The pleural effusion was sent for
cytological examination. The patient also underwent
resection of his renal mass and biopsy of the lung masses.
A diagnosis of RMC was made. Chemotherapy was initi-
ated. Despite aggressive treatment, the patient continued
to deteriorate and died 4 months after the diagnosis.
Case 2. A 13-year-old African-American female with a
history of sickle cell trait presented with shortness of
breath, back pain for several months, and hematuria for
one month. The CT scan showed a large (10 3 8.5 3
8 cm) right renal mass with retroperitoneal extension and
invasion of the inferior vena cava, multiple lung lesions,
a right sided pleural effusion and an enlarged supraclavic-
ular lymph node. The pleural effusion was sent for cyto-
logical examination. The patient underwent biopsy of the
right supraclavicular lymph node. The diagnosis of meta-
static RMC was made. Chemotherapy was initiated. The
patient was discharged after chemotherapy, but was read-
mitted a few weeks later with fever, vomiting and diar-
rhea. The patient’s condition continued to deteriorate. She
died 3 months after the diagnosis.
Pathological Findings
Cytological findings. Cytological examination of the
effusion specimens revealed numerous malignant cells in
a background of reactive mesothelial cells and mixed
inflammatory cells (Figs. C-1 and C-2). In both of our
cases, tumor cells were arranged predominantly in tight
clusters (Fig. C-1), two-dimensional groups and scattered
single cells (Fig. C-2), however, no true papillary frag-
ments with fibrovascular cores were identified. The tumor
cells had an epithelial appearance with high NC ratio and
large pleomorphic nuclei. The nuclei were often eccentri-
cally located with irregular nuclear membranes, and one
or several prominent nucleoli. The chromatin was finely
granular to vesicular in texture. The cytoplasm of the tu-
mor cells was dense and had two-tone appearance, and
distinct cell border. Many of the cells had vacuolated cyto-
plasm; and, in some instances, they indented the nuclei.
Histological findings. The surgical specimen of renal
mass of case 1 showed that the tumor was predominantly
raised from renal medulla. The tumor showed a compact
adenoid cystic and solid growth patterns with areas of
cystic degeneration (Figs. C-3A and B). The cells had
large hyperchromatic nuclei, irregular nuclear membranes,
fine to coarse chromatin, and one prominent or several
smaller nucleoli. Extensive necrosis and desmoplastic
stromal reaction were present. Foci of neutrophil infiltra-
tion and microabscess formation were present. Lymphatic
and blood vessel invasion were identified. Lymphoid infil-
tration was present at the periphery of the tumor. The bi-
opsy specimen of the right supraclavicular lymph node of
case 2 showed similar morphology to that of the renal
mass (Figs. C-3C and D).
Ancillary studies. Immunohistochemical studies were
performed on cell blocks. The tumor cells were diffusely
positive for cytokeratin AE1/AE3 and Cam5.2, and
focally positive for epithelial membrane antigen (EMA) and
CK7 in both cases. In one case, tumor cells were focally pos-
itive for vimentin, K903, monoclonal carcinoembryonic
antigen (mCEA). Tumor cells were negative for calretinin,
TTF-1, CK20, renal cell carcinoma (RCC), CD10, and Ulex
in both cases. Tumor cells were also negative for desmin and
myogenin. The selective immune results, such as Cam5.2,
Table I. Summary of Antibodies and Manufacturers
Antibodies Type Source Dilution Antigen retrieval
AE1/AE3 Monoclonal Ventana None None
CAM 5.2 Monoclonal Ventana Prediluted CC1
Vimentin Monoclonal Ventana 1:20 CC1
EMA Monoclonal Ventana Prediluted None
mCEA Monoclonal Ventana Prediluted CC1
CK7 Monoclonal Ventana 1:500 None
CK20 Monoclonal Ventana 1:20 CC1
K903 Monoclonal Ventana 1:20 None
Calretinin Polyoclonal Ventana 1:20 CC1
TTF-1 Monoclonal Ventana 1:500 CC1
RCC Monoclonal Ventana 1:10 Pronase
CD10 Monoclonal Ventana 1:20 CC1
Desmin Monoclonal Dako 1:100 CC1
Myogenin Monoclonal Ventana Prediluted None
CC1, cell conditioning solution; TTF-1, thyroid transcription factor-1;
RCC, renal cell carcinoma; EMA, epithelial membrane antigen; mCEA,
monoclonal carcinoembryonic antigen.
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Figs. C-1–C-2. Fig. C-1. Cytospin specimen of pleural effusion (Papanicolaou stain, 3100). The tumor cells are arranged predominantly in tight clus-
ters. No true papillary fragments with fibrovascular cores are present. The tumor cells have large hyperchromatic nuclei, irregular nuclear membranes,
fine to coarse chromatin, and one or several smaller prominent nucleoli. The cytoplasm contains vacuoles that displace or indent the nucleus. Fig. C-2.
Cytospin specimen of pleural effusion (Papanicolaou stain, A 340; B, C, and D 3100). Some area of the tumor cells are arranged in
two-dimensional groups and scattered single cells. In addition to hyperchromatic nuclei and nuclear atypia, the cytoplasm of the tumor cells also has a
two-tone appearance and distinct border.
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CK7, CK20, K903, EMA, mCEA, Ulex, and vimentin, were
shown in Figure C-4.
Discussion
The cytological findings of RMC have been reported in
the urine,11 in renal pelvic washings12 and in fine-needle
aspiration of renal masses.12,13 In both the exfoliative and
FNA specimens, the tumor cells predominantly form
loosely cohesive or two-dimensional clusters, and single
cells. In urine and pelvic washings, the tumor cells reveal
a high NC ratio, marked nuclear pleomorphism, irregular
nuclear membranes and prominent nucleoli. The cyto-
Figs. C-3–C-4. Fig. C-3. The surgical specimen of the renal mass of case 1 (A and B, H&E stain, 310 and 320). The tumor shows a compact
adenoid cystic and solid growth patterns (A). The cells have large hyperchromatic nuclei, irregular nuclear membranes, fine to coarse chromatin, and
one prominent or several smaller nucleoli. Tumor necrosis and desmoplastic stromal reaction are present. Foci of neutrophilic infiltrates and microab-
scesses formation are present (B). The biopsy specimen of the right supraclavicular lymph node of case 2 shows similar morphology to that of the renal
mass (C and D, H&E stain, 310 and 320). Fig. C-4. Immunohistochemical studies (320). The tumor cells are positive for cytokeratin Cam5.2 (340),
focally positive for CK7, K903, EMA, mCEA, vimentin; and negative for CK20 and Ulex.
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plasm is dense and granular with a sharply defined cyto-
plasmic border. The cytoplasm of the tumor cells also
contains multiple small vacuoles or a single large vacuole
that displaces and indents the nucleus.11,12 FNA cytology
of RMC reveals similar features such as nuclear pleomor-
phism, eccentric and irregular nuclei, prominent nucleoli
and vacuolated cytoplasm.13 None of these authors
has found true papillary configurations in the cytological
specimen.
Interestingly, both of our patients have right side pleu-
ral effusions, which are consistent with the observation
that the right kidney is involved three times more com-
monly than the left kidney in the series of 33 cases
reported by Davis et al.1 In our cases, the cytological
findings of the pleural effusions show similar features as
those seen in urine and FNA specimens. Taken together,
the most common findings from ours and others are
large tumor cells with pleomorphic nuclei and promi-
nent nucleoli, dense and vacuolated cytoplasm, and
distinct cytoplasmic borders. Although the tumor cells
form clusters, there are no true papillary configurations
present.
The differential diagnoses of RMC in the pleural effu-
sion are broad and include metastatic adenocarcinoma of
lung, renal cell carcinoma, urothelial cell carcinoma, and
collecting duct carcinoma. Adernocarcinoma of the lung
usually occurs in elderly patients. In exfoliative cytology,
adenocarcinoma may form three-dimensional tight clusters
and acinar structures. Some of the tumor cells may have
intracytoplasmic mucin. These features indicate glandular
differentiation.14 The nuclei of the tumor cells have
coarse chromatin, irregular nuclear membrane and promi-
nent nucleoli. The cytoplasm of the tumor cells is vesicu-
lar and lacy, and the cells do not have distinct cell bor-
ders.14 Immunohistochemical stains of tumor cells may be
helpful and are usually positive for CK7 and TTF-1.
Both renal cell carcinoma and urothelial cell carcinoma
have some overlapping features with RMC.1,2,6,7,12 How-
ever, the tumor cells of renal cell carcinoma form larger
clusters. The cells have a low NC ratio, uniform nuclei
and abundant clear or granular cytoplasm. The nuclei
have fine chromatin and inconspicuous nucleoli. The pres-
ence of fibrillary basement membrane material is also a
helpful feature for renal cell carcinoma.15 In urothelial
cell carcinoma, the tumor cells form clusters and single
cells. They have a large irregular hyperchromatic nuclei
and dense cytoplasm. The nuclei are eccentrically located
and with coarse chromatin.15 The presence of so-called
‘‘cercariform cells’’ is a clue for urothelial cell carci-
noma.16 The ‘‘cercariform cells’’ are large tumor cells
with a long cytoplasmic tails. Moreover, high-molecular-
weight cytokeratin K903 (34BE12) is positive in all uro-
thelial cell carcinomas studied by Caraway et al.17 and is
negative in all RMC studied by Swartz et al.7
The main differential diagnosis of RMC is collecting
duct carcinoma, since it shares substantial morphological
features with RMC.17 The tumor cells of collecting duct
carcinoma show moderate pleomorphism and are arranged
in two- or three-dimensional groups with papillary config-
urations. The nuclei are irregular with coarse chromatin
and prominent nucleoli. The cytoplasm is vacuolated.
Psammoma bodies have been reported to be present in
four of the seven fluid specimen examined.17 Clinically,
collecting duct carcinoma usually occurs in older patients
without sickle cell trait, especially in males with a mean
age of 53 year.18 To date, there are no specific immuno-
markers to differentiate between RMC and collecting duct
carcinoma.18 However, it has been reported that collecting
duct carcinomas are typically positive for cytokeratin
K903 and Ulex,18 whereas RMC are negative or focally
positive for cytokeratin K9032 and show variable staining
for Ulex.7,12 Other immuno markers, such as EMA, CEA
and vimentin, are reported to be variably expressed in
RMC.2 In our cases, the tumor cells are positive for cyto-
keratin AE1/AE3 and CAM5.2, negative or weakly,
focally positive for K903, and negative for Ulex. The
clinical history of sickle cell trait or disease is a key fac-
tor in distinguishing between these entities.
Davis CJ et al. has noted that some RMC had foci of
poorly differentiated cells. These cells have dense eosino-
philic cytoplasm and mimic those seen in rhabdoid tu-
mor.1 In addition, some authors have reported that it is
not uncommon for RMC to have a focal rhabdoid appear-
ance.2,4,12,13 Although we do not find these features in our
specimens, the differential diagnosis should also include
rhabdoid tumor, particularly in children and young adults.
Rhabdoid tumors usually present in the first 3 years of
life,19,20 whereas RMC usually occurs in older patients,
though the age range is broad.1,7 On cytology, rhabdoid
tumors contain large pleomorphic atypical cells with
dense cytoplasm or have features of small round cells.19,20
A tigroid background may be seen in some of the cases.
The tumor cells may stain positive for smooth muscle
actin, desmin and myogenin.20
Several genetic abnormalities have been suggested in
RMC. Stahlschmidt J et al. described a patient with the
bcr/abl rearrangement, as seen in chronic myelogenous
leukemia.3 Avery RA et al. reports a patient with multiple
abnormalities on chromosome 3 and 11.5 Swartz MA
et al. has found a patient with loss of chromosome 22.7
Yang XY et al. analyzes the gene expression profiles of
two cases of RMC and compares the results with renal
cell carcinoma and urothelial cell carcinoma. They have
found that the molecular signature of RMC clusters
closely with urothelial cell carcinoma of the renal pelvis,
rather than renal cell carcinoma.21 Recently, it has been
reported that loss of INI1 expression indicates aggressive
behavior in RMC.22 All these studies indicate the com-
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plexity of genetic abnormalities of RMC. Further studies
are needed to determine whether these findings have clini-
cal significance.
In summary, RMC has features of high-grade carci-
noma in the pleural effusion specimen, but may not be
readily recognized as renal in origin. The cytological fea-
tures include large tumor cells with distinct cell borders.
RMC should be considered in the differential diagnosis in
young patients with renal mass, particularly in those with
history of sickle cell trait or sickle cell disease.
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